News
News releases on March 30, 2026, page 21
Every news release public companies put out on March 30, 2026 (UTC): 2,235 news releases, newest first. Open any release to read it.
JFB Announces XTEND Becomes First U.S. Company to Receive U.S. Army Safety Board Approval for FPV Drone Programs
JFB Construction Holdings · Mar 30, 2026
Jeffs’ Brands Announces Corporate Name Change to Nexera Technologies and New Nasdaq Ticker Symbol “NEXR”
Nexera Technologies Ltd · Mar 30, 2026
JE Cleantech Secures approximately USD$12 million
JE Cleantech Holdings Limited · Mar 30, 2026
Jasper Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Corporate Update
Jasper Therapeutics, Inc. · Mar 30, 2026
Jack in the Box Inc. Announces Katelyn Zborowski as Chief Marketing Officer
Jack In the Box Inc. · Mar 30, 2026
IPVanish Launches Full-Scale Digital Security, Continuing Expansion Beyond VPN Service With Threat Protection Pro
Ziff Davis, Inc. · Mar 30, 2026
Invivyd Announces Presentation at the World Vaccine Congress Washington
Invivyd, Inc. · Mar 30, 2026
Investcorp Credit Management BDC, Inc. Announces Financial Results for the Quarter and Year Ended December 31, 2025
Investcorp Credit Management BDC, Inc. · Mar 30, 2026
Intercont (Cayman) Limited Announces Effective Time of Share Consolidation/Reverse Share Split to Regain NASDAQ Compliance
Intercont (Cayman) Limited · Mar 30, 2026
Integra Resources Grants Annual Incentive Awards
Integra Resources Corp · Mar 30, 2026
Insulet Appoints Mike Panos as Chief Commercial Officer
Insulet Corporation · Mar 30, 2026
Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Inogen, Inc · Mar 30, 2026
Inogen Announces Leadership Appointments Designed to Accelerate Next Phase of Growth
Inogen, Inc · Mar 30, 2026
Innventure Reports Fourth Quarter and Full Year 2025 Results
Innventure, Inc. · Mar 30, 2026
INmune Bio Inc. Announces 2025 Results and Provides Business Update
INmune Bio Inc. · Mar 30, 2026
Immix Biopharma Announces Enrollment Completion of BLA-Enabling Relapsed/Refractory AL Amyloidosis Trial NEXICART-2, and Upcoming Milestones
Immix Biopharma, Inc. · Mar 30, 2026
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Combination Study of IDE849, DLL3 TOP1 ADC, and IDE161, PARG Inhibitor, in DLL3...
IDEAYA Biosciences, Inc. · Mar 30, 2026
ICG Silver & Gold Closes $1.73 Million Unit Offering, Bringing Aggregate Gross Proceeds Raised to $6.20 Million, and Confirms March 31 Tr...
ICG Silver & Gold Ltd. · Mar 30, 2026
Huntington Bancshares Incorporated Declares Cash Dividend On Its Series I & Series L Preferred Stock
Huntington Bancshares Incorporated · Mar 30, 2026
Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq: NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powe...
NRX Pharmaceuticals, Inc. · Mar 30, 2026
Herbalife to Expand Its Personalized Nutritional Supplement Capabilities Through Planned Acquisition of Bioniq
Herbalife Ltd. · Mar 30, 2026
HealthEquity Appoints Sanford Health CEO Bill Gassen to Board of Directors
HealthEquity, Inc. · Mar 30, 2026
Guardant Health’s InfinityAI Real-World Evidence Supports Approval of ENHERTU® for Previously Treated Patients with HER2-Positive Metasta...
Guardant Health, Inc. · Mar 30, 2026
Goosehead Insurance, Inc. Announces Appointment of Martin Thornthwaite as General Counsel and Corporate Secretary
Goosehead Insurance, Inc. · Mar 30, 2026
Gold Orogen Resources Drills and Further Tests Continuation of Williams Brook Gold Mineralization Trend at Mcintyre Brook, New Brunswick
Gold Orogen Resources Corp. · Mar 30, 2026
Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights
GlucoTrack, Inc. · Mar 30, 2026
Global Interactive Technologies Secures Up to $18 Million Strategic Capital Facility to Support Growth Initiatives
Global Interactive Technologies, Inc. · Mar 30, 2026
Giftify’s CardCash Reports 14.2% Sell-Side Volume Growth and 18.5% Rise in New Seller Acquisition Through Early Q1 2026, Expanding Platfo...
Giftify, Inc. · Mar 30, 2026
Gevo Announces it is Developing Plans for Major Ethanol Expansion at Richardton, North Dakota Facility
Gevo, Inc. · Mar 30, 2026
Genasys Inc. Appoints Larry Hagenbuch to Board of Directors
Genasys Inc. · Mar 30, 2026
Functional Brands Announces Fourth Quarter and Full-Year 2025 Financial Results
Functional Brands, Inc. · Mar 30, 2026
Fortress Biotech’s Subsidiary Cyprium Therapeutics Closes Sale of Rare Pediatric Disease Priority Review Voucher for $205 Million
Fortress Biotech, Inc. · Mar 30, 2026
Flex Announces Agreement to Acquire Electrical Power Products (EP²)
Flex Ltd. · Mar 30, 2026
Financial Institutions, Inc. Schedules First Quarter 2026 Earnings Release and Conference Call
Financial Institutions, Inc. · Mar 30, 2026
Fermi America™ Reports Fiscal Year 2025 Earnings, Marking Operational Milestones on the Path to 17 GW of Private Power
Fermi Inc. · Mar 30, 2026
FDA Approves New High Dose Regimen of SPINRAZA® (nusinersen) for Spinal Muscular Atrophy
Biogen Inc. · Mar 30, 2026
Fathom Holdings Reports Fourth Quarter and Full Year 2025 Results
Fathom Holdings Inc. · Mar 30, 2026
Fastenal Celebrates 25 Years in Mexico
Fastenal Company · Mar 30, 2026
Falcon’s Beyond Reports Fourth Quarter and Full Year 2025 Financial Results
Falcon's Beyond Global, Inc. · Mar 30, 2026
Esperion Showcases New Data from CLEAR Outcomes Highlighting Value of NEXLETOL® (bempedoic acid) at the American College of Cardiology’s ...
Esperion Therapeutics, Inc. · Mar 30, 2026
ePLDT Group Powers Enterprise Transformation, Customer-Centric Innovation with CSG
CSG Systems International, Inc. · Mar 30, 2026
Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results
Ensysce Biosciences, Inc. · Mar 30, 2026
Enanta Pharmaceuticals to Present Data for its STAT6 Inhibitor Program at IMMUNOLOGY2026TM, the Annual Meeting of the American Associatio...
Enanta Pharmaceuticals, Inc. · Mar 30, 2026
Electro-Sensors, Inc. Announces 2025 Year-End Financial Results
Electro-Sensors, Inc. · Mar 30, 2026
East West Bancorp Announces Dates for Second Quarter and Third Quarter 2026 Earnings Calls, June Conference Participation
East West Bancorp, Inc. · Mar 30, 2026
EagleOne Metals Completes Acquisition of Poison Springs Uranium / Rare Earths Project
EagleOne Metals Corporation · Mar 30, 2026
DiaMedica Therapeutics Reports Full Year 2025 Financial Results and Provides Business Highlights
DiaMedica Therapeutics Inc. · Mar 30, 2026
Denarius Metals Announces Positive PEA Results For Its 100%-owned Zancudo Project In Colombia
Denarius Metals Corp. · Mar 30, 2026
Definium Therapeutics Announces New Employee Inducement Grants
Definium Therapeutics, Inc. · Mar 30, 2026
DeFi Development Corp. Reports +442% Revenue Growth for FY 2025
DeFi Development Corp. · Mar 30, 2026
DAWSON GEOPHYSICAL REPORTS FOURTH QUARTER and YEAR END 2025 RESULTS
Dawson Geophysical Company · Mar 30, 2026
Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations ...
iRhythm Holdings, Inc. · Mar 30, 2026
CXApp Inc. Reports FY 2025 Results; Unveils 2026 Strategic Outlook Powered by Agentic AI Platform
CXApp Inc. · Mar 30, 2026
CVD Equipment Corporation Reports Fourth Quarter and Fiscal Year 2025 Results
CVD Equipment Corporation · Mar 30, 2026
Curanex Provides Business Update in Connection with 2025 Annual Report as Phyto-N Advances Toward Planned IND Submission
Curanex Pharmaceuticals Inc · Mar 30, 2026
Connect Biopharma Announces Positive Topline Data from its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD
Connect Biopharma Holdings Limited · Mar 30, 2026
Connect Biopharma Announces $20.2 Million Private Placement Financing
Connect Biopharma Holdings Limited · Mar 30, 2026
Comcast Continues Expansion of Reliable, High-Speed Internet Across Merrimack County, New Hampshire
Comcast Corporation · Mar 30, 2026
Comcast Completes Network Expansion to More Than 5,200 Homes and Businesses in East Nottingham and Oxford Borough
Comcast Corporation · Mar 30, 2026
Comcast Business Launches Total Solutions Advantage: Simplified, All-In Plans for Small Businesses Starting at $60 per Month
Comcast Corporation · Mar 30, 2026
Clearmind Medicine Announces Successful Completion of Treatment and Follow-up for 18 Participants in its Ongoing Phase I/IIa Clinical Tri...
Clearmind Medicine Inc. · Mar 30, 2026
Clean Energy Technologies Advances First Waste-to-Energy Deployment in Alberta Under LOI with Hoppy Power, Targeting Scalable Rollout
Clean Energy Technologies, Inc. · Mar 30, 2026
Champions Oncology Names Brian Alexander to Board as Company Advances Data-Driven Oncology Strategy
Champions Oncology, Inc. · Mar 30, 2026
CBAK Energy Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results
CBAK Energy Technology, Inc. · Mar 30, 2026
Cass Commercial Bank Names Eric Giering President
Cass Information Systems, Inc · Mar 30, 2026
Capstone Expands Commercial Market Reach with KLAD Integration, Unlocking High-Margin, Asset-Light Revenue Growth
Capstone Holding Corp. · Mar 30, 2026
Camtek receives $31 million multi-system order from a leading osat
Camtek Ltd. · Mar 30, 2026
Caliber Announces Conversion of $15.9 Million of Preferred Equity into Common Stock
CaliberCos Inc. · Mar 30, 2026
BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Majo...
Bullfrog AI Holdings, Inc. · Mar 30, 2026
Buchanan Ingersoll & Rooney will use Intapp AI-powered software for modern, compliant timekeeping practices
Intapp, Inc. · Mar 30, 2026
BridgeBio Submits NDA to FDA for BBP-418 for Individuals Living with LGMD2I/R9
BridgeBio Pharma, Inc. · Mar 30, 2026
BRC Group Holdings, Inc. Launches BRC Specialty Finance
BRC Group Holdings, Inc. · Mar 30, 2026
BNKK Hits 233% of Internal Q1 Revenue Target; Reports $6.4M in Platform Revenue
Bonk, Inc. · Mar 30, 2026
Bitdeer Engages DCI to Finalise Development of Norway’s Largest AI Data Center
Bitdeer Technologies Group · Mar 30, 2026
BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in...
BioRestorative Therapies, Inc. · Mar 30, 2026
Bio Green Med Solution reports fourth quarter and full year 2025 financial results and provides business update
Bio Green Med Solution, Inc. · Mar 30, 2026
Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Bicara Therapeutics Inc. · Mar 30, 2026
BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026
BeyondSpring, Inc. · Mar 30, 2026
Beta Bionics to Announce First Quarter 2026 Financial Results on April 21, 2026
Beta Bionics, Inc. · Mar 30, 2026
Backblaze Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Backblaze, Inc. · Mar 30, 2026
Axcelis Announces SBTi Approval of Science-Based Greenhouse Gas Emissions Reduction Targets
Axcelis Technologies, Inc. · Mar 30, 2026
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right
Aurinia Pharmaceuticals Inc · Mar 30, 2026
Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Aura Biosciences, Inc. · Mar 30, 2026
AudioCodes Announces Filing of Form 20-F for the Fiscal Year Ended December 31, 2025
AudioCodes Ltd. · Mar 30, 2026
Asure Appoints Tiffany Mortimer as Chief Transformation & People Officer
Asure Software Inc · Mar 30, 2026
Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Artelo Biosciences, Inc. · Mar 30, 2026
Armory Mining Applies To Canadian Association Of Defence And Security Industries To Advance Its Critical Minerals Strategy
Armory Mining Corp. · Mar 30, 2026
ARKO Petroleum Corp. Reports Fourth Quarter and Full Year 2025 Results
ARKO Petroleum Corp. · Mar 30, 2026
ArcWest Exploration Grants Stock Options
ArcWest Exploration Inc. · Mar 30, 2026
Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm™ (dibutepinephrine) Sublingual Film
Aquestive Therapeutics, Inc. · Mar 30, 2026
Aprea Therapeutics Announces Oversubscribed $30 Million Private Placement
Aprea Therapeutics, Inc. · Mar 30, 2026
Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
Annexon, Inc. · Mar 30, 2026
Anixa Biosciences Announces Presentation of its Ovarian Cancer CAR-T Therapy Clinical Trial at the Society of Gynecologic Oncology Annual...
Anixa Biosciences, Inc. · Mar 30, 2026
AngloGold Ashanti Holdings plc Announces Capped Cash Tender Offers for Part of Its 3.375% Notes Due 2028, 3.750% Notes Due 2030 and 6.500...
AngloGold Ashanti PLC · Mar 30, 2026
Anavex Life Sciences Provides Comprehensive Regulatory Update
Anavex Life Sciences Corp. · Mar 30, 2026
Alvotech Publishes 2025 Annual Report
Alvotech · Mar 30, 2026
Alvotech Files Annual Report with the SEC
Alvotech · Mar 30, 2026
Alvotech files Annual Report with the SEC
Alvotech · Mar 30, 2026
Allbirds Signs Definitive Asset Purchase Agreement with American Exchange Group
Allbirds, Inc. · Mar 30, 2026
AleAnna, Inc. Reports Fourth Quarter and Full Year 2025 Results
AleAnna, Inc. · Mar 30, 2026